March 4, 2019 / 7:19 AM / 3 months ago

Biogen to buy Nightstar Therapeutics for about $800 mln

March 4 (Reuters) - Biogen Inc said on Monday it will buy Nightstar Therapeutics Plc for about $800 million in cash.

Biogen’s offer of $25.50 per share, represents a premium of 68 percent to Nightstar’s Friday close of $15.16. (Reporting by Rishika Chatterjee in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below